PDGF ‐D Promotes Epithelial–Mesenchymal Transition of Glioma Cells Through the NF ‐ κB / NOTCH1 Pathway
Cancer Medicine · 2025
DOI: 10.1002/cam4.71002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yao Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, Second Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Receptor, Notch1, Glioma, Lymphokines. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Finance of Jilin Province, Jilin Provincial Scientific and Technological Development Program.
Abstract (Originalsprache)
Background
Platelet‐derived growth factor‐D (PDGF‐D) is expressed at high levels in various tumors and is involved in epithelial–mesenchymal transition (EMT) and the malignant behavior of cancer cells. However, its role in glioma progression and the underlying molecular mechanisms remain unclear.
Methods
We used data from the Chinese Glioma Genome Atlas to evaluate the correlation among PDGF‐D expression, tumor grade, and phenotype of glioma. The in situ expression of PDGF‐D in clinical glioma specimens was analyzed through immunohistochemistry. Colony formation assays and transwell assays were performed for functional evaluation of glioma cell lines with PDGF‐D knockdown or overexpression. Western blotting and RT‐qPCR were conducted to explore molecular mechanisms.
Results
PDGF‐D was significantly upregulated in high‐grade glioma and was associated with the malignant phenotype and poor prognosis. Knocking down PDGF‐D in the LN18 glioma cell line reduced the expression of phosphorylated p65 and NOTCH1 and inhibited clonal proliferation, migration, invasion, and the EMT program. In contrast, inhibiting p65 phosphorylation in glioma cells overexpressing PDGF‐D led to the downregulation of NOTCH1 and reversed EMT.
Conclusion
PDGF‐D promotes the invasion and migration of glioma cells by activating the NF‐κB/NOTCH1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Blood Transfusion, Second Hospital of Jilin University, Changchun, China.
- Department of Neurosurgery, First Hospital of Jilin University, Changchun, China.
ORCID-Profile: Yao Zhao, Mingbo Jia, Liyan Zhao
Förderung
- Department of Finance of Jilin Province
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Li, Y., Zhao, Y., Shi, M., Ma, X., Jia, M., Shen, Z., Liu, X., Li, Y., & Zhao, L. (2025). PDGF ‐D Promotes Epithelial–Mesenchymal Transition of Glioma Cells Through the NF ‐ κB / NOTCH1 Pathway. Cancer Medicine. https://doi.org/10.1002/cam4.71002
Vancouver
Li Y, Zhao Y, Shi M, Ma X, Jia M, Shen Z, et al. PDGF ‐D Promotes Epithelial–Mesenchymal Transition of Glioma Cells Through the NF ‐ κB / NOTCH1 Pathway. Cancer Medicine. 2025. doi:10.1002/cam4.71002
BibTeX
@article{Li2025,
author = {Li, Yao and Zhao, Yao and Shi, Minghao and Ma, Xiaoshan and Jia, Mingbo and Shen, Zhongjun and Liu, Xiaoyi and Li, Yunqian and Zhao, Liyan},
title = {PDGF ‐D Promotes Epithelial–Mesenchymal Transition of Glioma Cells Through the NF ‐ κB / NOTCH1 Pathway},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71002}
}
EUVIMED